These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8865128)

  • 21. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer--a randomised study.
    Halme M; Maasilta PK; Pyrhönen SO; Mattson KV
    Eur J Cancer; 1994; 30A(1):11-5. PubMed ID: 8142151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancer.
    Saito H; Shimokata K; Saka H; Yamamoto M; Ogasawara T; Nomura F; Sakai S; Iwata M; Murate T; Miyachi T
    Cancer Chemother Pharmacol; 1993; 33(2):154-6. PubMed ID: 8261575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.
    Nakanishi Y; Takayama K; Kawasaki M; Yatsunami J; Inutsuka S; Wakamatsu K; Tsuruta N; Hara N
    Am J Clin Oncol; 1997 Aug; 20(4):393-7. PubMed ID: 9256897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
    Sculier JP; Paesmans M; Thiriaux J; Lecomte J; Bureau G; Giner V; Efremidis A; Lafitte JJ; Berchier MC; Alexopoulos CG; Zacharias C; Mommen P; Ninane V; Klastersky J
    J Clin Oncol; 1998 Apr; 16(4):1388-96. PubMed ID: 9552042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group.
    Font A; Moyano AJ; Puerto JM; Tres A; Garcia-Giron C; Barneto I; Anton A; Sanchez JJ; Salvador A; Rosell R
    Cancer; 1999 Feb; 85(4):855-63. PubMed ID: 10091762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Graziano SL; Valone FH; Herndon JE; Crawford J; Richards F; Rege VB; Clamon G; Green MR
    Lung Cancer; 1996 Jun; 14(2-3):315-29. PubMed ID: 8794413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.
    Ali MA; Kraut MJ; Valdivieso M; Wozniak AJ; Cummings G; Kalemkerian GP
    Cancer Invest; 2000; 18(1):1-5. PubMed ID: 10701360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group.
    Nakanishi Y; Kawarada Y; Hirose N; Ninomiya K; Miyazaki M; Miyazaki N; Kurita Y; Kanegae H; Ohgushi O; Ogata K; Yamazaki H; Inutsuka S; Hara N
    Cancer Chemother Pharmacol; 1998; 41(6):453-6. PubMed ID: 9554588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
    Johnson DH; DeVore R; Greco FA; Walls J; Thomas M; Hande KR; Hainsworth JD
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):50-6. PubMed ID: 1329223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
    Cellerino R; Tummarello D; Guidi F; Isidori P; Raspugli M; Biscottini B; Fatati G
    J Clin Oncol; 1991 Aug; 9(8):1453-61. PubMed ID: 1649267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group.
    Nyman J; Friesland S; Hallqvist A; Seke M; Bergström S; Thaning L; Lödén B; Sederholm C; Wagenius G
    Lung Cancer; 2009 Jul; 65(1):62-7. PubMed ID: 19081652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.
    Ahn JB; Ko WK; Lee JG; Shim KY; Jeung HC; Park JO; Yoo NC; Kim BS; Kim SK; Kim SK; Kim JH
    Am J Clin Oncol; 2000 Dec; 23(6):622-8. PubMed ID: 11202811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
    Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An early phase II trial combining cisplatin and carboplatin in advanced non-small cell lung cancer].
    Yoshimura A; Yamano Y; Gemma A; Yoshimori K; Hayashihara K; Taniguchi Y; Uematsu K; Shibuya M; Kudoh S; Niitani H
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):503-8. PubMed ID: 8383951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taxol (paclitaxel) in the treatment of lung cancer: the Eastern Cooperative Oncology Group experience.
    Johnson DH; Chang AY; Ettinger DS
    Ann Oncol; 1994; 5 Suppl 6():S45-50. PubMed ID: 7865434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.
    Crinò L; Latini P; Meacci M; Corgna E; Maranzano E; Darwish S; Minotti V; Santucci A; Tonato M
    Ann Oncol; 1993 Dec; 4(10):847-51. PubMed ID: 8117604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Spigel DR; Luft A; Depenbrock H; Ramlau R; Khalil M; Kim JH; Mayo C; Chao GY; Obasaju C; Natale R
    Clin Lung Cancer; 2017 Sep; 18(5):480-488. PubMed ID: 28365238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin.
    Rowinsky EK; Jiroutek M; Bonomi P; Johnson D; Baker SD
    Clin Cancer Res; 1999 Apr; 5(4):767-74. PubMed ID: 10213211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.